|
Safety and efficacy of tofacitinib for immune skin conditions in Down syndrome
Childrens Hospital Colorado, Outpatient CTRC, Outpatient CTRC, University of Colorado Hospital This study is designed to determine whether tofacitinib is a safe and effective treatment for immune skin conditions in adults with Down syndrome, and to further our understanding of the immune system in Down syndrome. This is a single arm, open-label study. All participants will receiv... |
|
Development and Validation of an Ancillary Diagnostic Test for Mycosis Fungoides (SIGNAL-MF)
Department Specific Free Standing Clinic, University of Colorado Hospital Castle Biosciences, Incorporated (CSTL) recently developed and validated a 35-GEP test to aid in the diagnosis of difficult- to-diagnose primary cutaneous melanocytic neoplasms and to improve accuracy when used in combination with currently applied diagnostic tools. Ambiguous lesions repre... |
|
An International, Multicenter, Randomized, Double-Blind, Parallel
Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension
Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the
Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Childrens Hospital Colorado International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study with Open-Label Extension ... |